Skip to content

Treatment of Swallowing disorders in stroke patients

Comparative Study of effectiveness of Combined treatment of dysphagia(Traditional Dysphagia Therapy &Transcranial Magnetic Stimulation) and other two treatments in Stroke Patients".

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202218629N1
Enrollment
15
Registered
2013-03-27
Start date
2012-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia. Difficulty in swallowing

Interventions

Rehabilitation
Treatment - Devices
Intervention 1: Control Group : The first group are provided traditional dysphagia therapy. this protocol is included competional treatments , postural changes, oromotor exercies and swallowind manuer
Control Group : The first group are provided traditional dysphagia therapy. this protocol is included competional treatments , postural changes, oromotor exercies and swallowind manuers. this treatmen
Intervention Group : The second group are provided inhibitory Repatative Transcranial Magnetic Stimulations (rTMS) in healty hemisphere. Stimulations were performed at 1 Hz for 20 min at 20% above th
Intervention Group: The third group is given combined treatment(TDT and rTMS). Firstly patients are given rTMS for 5 day and Simultaneously are given TDT for 3days in week for 6 weeks. In every day t

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1-Subacute(at least one week after the accuring of stroke) Stroke patient with dysphagia 2-Patients' rang of age is between 20-80 3-Patients from Both gender 4-Suffering from dysphagia and aspiration diagnosed by MASA(Mann Assessment of Swallowing Ability) 5- they have not received any Dysphagia therapy. Exclusion Criteria: 1- Dementia and Alzheimer and dysphagia due to other neurogenic Disease 2_ Significant reflux 3- Severe Aphasia 4_ Dysphagia due to drug toxicity 5- severe Reflux 6_ Agitation, with decreased level of consciousness, or otherwise noncompliant 7_ Pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Score of MASA test. Timepoint: Before treatment,5th session,10th session,the end of forth week of treatment and the end of sixth week of treatment. Method of measurement: MASA test.;Dysphagia. Timepoint: Before treatment,5th session,10th session,the end of forth week of treatment and the end of sixth week of treatment. Method of measurement: MASA test.;Severity of Dysphagia. Timepoint: Before treatment,5th session,10th session,the end of forth week of treatment and the end of sixth week of treatment. Method of measurement: MASA test.;Aspiration. Timepoint: Before treatment,5th session,10th session,the end of forth week of treatment and the end of sixth week of treatment. Method of measurement: MASA test.;Severity of Aspiration. Timepoint: Before treatment,5th session,10th session,the end of forth week of treatment and the end of sixth week of treatment. Method of measurement: MASA test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Ghelichi

Tehran University of Medical Sciences

l-ghelichi@razi.tums.ac.ir ,lghelichi@gmail.com+98 21 2222 8051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026